BioCentury | Feb 10, 2014
Financial News

NeuroVive completes rights offering

...SEK85.8 million ($13.1 million) Shares: 6.1 million Price: SEK14 Shares after offering: 27.8 million Advisor: Erik Penser Bankaktiebolag...
BioCentury | Jan 13, 2014
Financial News

NeuroVive proposes rights offering

...To be raised: Up to SEK75.8 million ($11.6 million) Shares: 5.4 million Price: SEK14 Advisor: Erik Penser Bankaktiebolag...
BioCentury | Jun 3, 2013
Financial News

PledPharma completes rights offering

...million ($2.8 million) Shares: 1.7 million Price: SEK11 Shares after offering: 21.9 million Placement agent: Erik Penser Bankaktiebolag...
BioCentury | Apr 8, 2013
Financial News

PledPharma proposes rights offering

...be raised: Up to SEK18.6 million ($2.8 million) Shares: 1.7 million Price: SEK11 Placement agent: Erik Penser Bankaktiebolag...
Items per page:
1 - 4 of 4
BioCentury | Feb 10, 2014
Financial News

NeuroVive completes rights offering

...SEK85.8 million ($13.1 million) Shares: 6.1 million Price: SEK14 Shares after offering: 27.8 million Advisor: Erik Penser Bankaktiebolag...
BioCentury | Jan 13, 2014
Financial News

NeuroVive proposes rights offering

...To be raised: Up to SEK75.8 million ($11.6 million) Shares: 5.4 million Price: SEK14 Advisor: Erik Penser Bankaktiebolag...
BioCentury | Jun 3, 2013
Financial News

PledPharma completes rights offering

...million ($2.8 million) Shares: 1.7 million Price: SEK11 Shares after offering: 21.9 million Placement agent: Erik Penser Bankaktiebolag...
BioCentury | Apr 8, 2013
Financial News

PledPharma proposes rights offering

...be raised: Up to SEK18.6 million ($2.8 million) Shares: 1.7 million Price: SEK11 Placement agent: Erik Penser Bankaktiebolag...
Items per page:
1 - 4 of 4